MicrobiotiX Receives IND Approval for Novel Bacteriophage Drug MP101
MicrobiotiX Receives IND Approval for Novel Bacteriophage Drug MP101 Korea's First Bacteriophage IND Approved by the Ministry of Food and Drug Safety – Phase 1 Trial to Begin in Patients with Acute Pneumonia GlobeNewswire October 27, 2025 SEOUL, South Korea, Oct. 27, 2025 (GLOBE NEWSWIRE) — MicrobiotiX Co., Ltd. (CEO Dongeun Yong), a company specializing […]